Pacific Biosciences Of California | PACB - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Agilent USD 399M 46M 2026-03
Bruker USD 69.6M 59.4M 2026-06
Danaher USD 1.13B 217M 2026-06
General Electric Aerospace USD 2.32B 549M 2026-03
Illumina USD 260M 21M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quidel USD -15.3M 16.5M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD -86M 234M 2026-06